| 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
914 |
| Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association |
376 |
| First Pass Effect: A New Measure for Stroke Thrombectomy Devices |
58 |
| Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study |
52 |
| Diagnosis of Cerebral Amyloid Angiopathy Evolution of the Boston Criteria |
49 |
| Recommendations for the Establishment of Stroke Systems of Care: A 2019 Update A Policy Statement From the American Stroke Association |
43 |
| Accuracy of Prediction Instruments for Diagnosing Large Vessel Occlusion in Individuals With Suspected Stroke: A Systematic Review for the 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke |
42 |
| Human Neural Stem Cell Extracellular Vesicles Improve Recovery in a Porcine Model of Ischemic Stroke |
41 |
| Selective NLRP3 (Pyrin Domain-Containing Protein 3) Inflammasome Inhibitor Reduces Brain Injury After Intracerebral Hemorrhage |
38 |
| Management of Stroke in Neonates and Children: A Scientific Statement From the American Heart Association/American Stroke Association |
37 |
| Thrombus Neutrophil Extracellular Traps Content Impair tPA-Induced Thrombolysis in Acute Ischemic Stroke |
36 |
| Minimally Invasive Surgery for Intracerebral Hemorrhage: An Updated Meta-Analysis of Randomized Controlled Trials |
35 |
| Blood Pressure Variability Predicts Poor In-Hospital Outcome in Spontaneous Intracerebral Hemorrhage |
31 |
| Mechanical Thrombectomy in Patients With Milder Strokes and Large Vessel Occlusions A Multicenter Matched Analysis |
29 |
| SCIL-STROKE (Subcutaneous Interleukin-1 Receptor Antagonist in Ischemic Stroke) A Randomized Controlled Phase 2 Trial |
28 |
| WEAVE Trial Final Results in 152 On-Label Patients |
28 |
| Periodontal Disease, Regular Dental Care Use, and Incident Ischemic Stroke |
27 |
| Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis |
26 |
| Modified Thrombolysis in Cerebral Infarction 2C/Thrombolysis in Cerebral Infarction 3 Reperfusion Should Be the Aim of Mechanical Thrombectomy Insights From the ASTER Trial (Contact Aspiration Versus Stent Retriever for Successful Revascularization) |
26 |
| Rescue Stenting for Failed Mechanical Thrombectomy in Acute Ischemic Stroke A Multicenter Experience |
26 |
| Endovascular Thrombectomy for Mild Strokes: How Low Should We Go? A Multicenter Cohort Study |
24 |
| Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes A Systematic Review and Meta-Analysis |
24 |
| Blood Pressure and Outcome After Mechanical Thrombectomy With Successful Revascularization A Multicenter Study |
22 |
| Radial Artery Catheterization for Neuroendovascular Procedures Clinical Outcomes and Patient Satisfaction Measures |
22 |
| Successful Reperfusion With Intravenous Thrombolysis Preceding Mechanical Thrombectomy in Large-Vessel Occlusions |
21 |
| Recanalization Rate per Retrieval Attempt in Mechanical Thrombectomy for Acute Ischemic Stroke |
21 |
| Prediction of Tissue Outcome and Assessment of Treatment Effect in Acute Ischemic Stroke Using Deep Learning |
21 |
| Surgical Management of Moyamoya Disease |
21 |
| Functional Outcome Following Stroke Thrombectomy in Clinical Practice |
20 |
| Serum Trimethylamine N-Oxide Concentration Is Positively Associated With First Stroke in Hypertensive Patients |
20 |
| Association of Blood Pressure During Thrombectomy for Acute Ischemic Stroke With Functional Outcome: A Systematic Review |
20 |
| High Neutrophil-to-Lymphocyte Ratio Predicts Stroke-Associated Pneumonia |
20 |
| Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats |
20 |
| Atrial Cardiopathy and the Risk of Ischemic Stroke in the CHS (Cardiovascular Health Study) |
20 |
| Number of Stent Retriever Passes Associated With Futile Recanalization in Acute Stroke |
19 |
| Role of Blood Lipids in the Development of Ischemic Stroke and its Subtypes A Mendelian Randomization Study |
19 |
| Beyond Large Vessel Occlusion Strokes: Distal Occlusion Thrombectomy |
19 |
| Machine Learning-Based Model for Prediction of Outcomes in Acute Stroke |
19 |
| Phase I/II Study of Safety and Preliminary Efficacy of Intravenous Allogeneic Mesenchymal Stem Cells in Chronic Stroke |
19 |
| Stroke Among Young West Africans Evidence From the SIREN (Stroke Investigative Research and Educational Network) Large Multisite Case-Control Study |
18 |
| Frequency of Patent Foramen Ovale and Migraine in Patients With Cryptogenic Stroke |
18 |
| Predicting Intracerebral Hemorrhage Expansion With Noncontrast Computed Tomography The BAT Score |
18 |
| Systematic Review on Kinematic Assessments of Upper Limb Movements After Stroke |
18 |
| IL-23 (Interleukin-23)-Producing Conventional Dendritic Cells Control the Detrimental IL-17 (Interleukin-17) Response in Stroke |
18 |
| Novel Telestroke Program Improves Thrombolysis for Acute Stroke Across 21 Hospitals of an Integrated Healthcare System |
18 |
| Randomized Sham-Controlled Trial of Navigated Repetitive Transcranial Magnetic Stimulation for Motor Recovery in Stroke The NICHE Trial |
17 |
| Mechanical Thrombectomy in Ischemic Stroke Patients With Alberta Stroke Program Early Computed Tomography Score 0-5 |
17 |
| Diabetes Mellitus Impairs White Matter Repair and Long-Term Functional Deficits After Cerebral Ischemia |
17 |
| Eligibility for Endovascular Trial Enrollment in the 6-to 24-Hour Time Window Analysis of a Single Comprehensive Stroke Center |
17 |
| Risk Factors for Poststroke Cognitive Decline The REGARDS Study (Reasons for Geographic and Racial Differences in Stroke) |
17 |
